Birdwatch Archive

Birdwatch Note

2023-06-27 17:43:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Many non profit healthcare providers in Europe are reviewing the benefits, risks and long term impact of ‘gender affirming healthcare’ i.e. puberty blockers and hormone treatment for children. Discussing European policy would be banned under this proposal. https://www.bbc.co.uk/news/uk-65860272.amp https://www.irishtimes.com/health/2023/06/27/use-of-puberty-blockers-in-childrens-gender-service-to-be-reviewed/ https://www.forbes.com/sites/joshuacohen/2023/06/06/increasing-number-of-european-nations-adopt-a-more-cautious-approach-to-gender-affirming-care-among-minors/amp/ https://www.nationalreview.com/corner/frances-academy-of-medicine-urges-great-medical-caution-in-blocking-puberty/ https://amp.france24.com/en/live-news/20230208-sweden-puts-brakes-on-treatments-for-trans-minors https://www.theatlantic.com/health/archive/2023/04/gender-affirming-care-debate-europe-dutch-protocol/673890/

Written by E0CDF87851C0605778C4D87146C8976C94A5C5880ED6A0BC7A8C5E1A6C5DBD74
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1673677672713531406

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1673748987038277636
  • noteId - 1673748987038277636
  • participantId -
  • noteAuthorParticipantId - E0CDF87851C0605778C4D87146C8976C94A5C5880ED6A0BC7A8C5E1A6C5DBD74 Participant Details
  • createdAtMillis - 1687887829921
  • tweetId - 1673677672713531406
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 1
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Many non profit healthcare providers in Europe are reviewing the benefits, risks and long term impact of ‘gender affirming healthcare’ i.e. puberty blockers and hormone treatment for children. Discussing European policy would be banned under this proposal. https://www.bbc.co.uk/news/uk-65860272.amp https://www.irishtimes.com/health/2023/06/27/use-of-puberty-blockers-in-childrens-gender-service-to-be-reviewed/ https://www.forbes.com/sites/joshuacohen/2023/06/06/increasing-number-of-european-nations-adopt-a-more-cautious-approach-to-gender-affirming-care-among-minors/amp/ https://www.nationalreview.com/corner/frances-academy-of-medicine-urges-great-medical-caution-in-blocking-puberty/ https://amp.france24.com/en/live-news/20230208-sweden-puts-brakes-on-treatments-for-trans-minors https://www.theatlantic.com/health/archive/2023/04/gender-affirming-care-debate-europe-dutch-protocol/673890/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-06-27 17:43:49 UTC
(1687887829921)
1969-12-31 23:59:59 UTC
(-1)
2023-06-28 02:10:31 UTC
(1687918231836)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-06-27 18:38:33 -0500 Rating Details
2023-06-27 18:36:15 -0500 Rating Details
2023-06-27 17:12:08 -0500 Rating Details
2023-06-27 16:56:45 -0500 Rating Details
2023-06-27 16:11:22 -0500 Rating Details
2023-06-27 16:03:19 -0500 Rating Details
2023-06-27 16:03:17 -0500 Rating Details
2023-06-27 15:48:26 -0500 Rating Details
2023-06-27 15:40:18 -0500 Rating Details
2023-06-27 15:31:33 -0500 Rating Details
2023-06-27 15:07:31 -0500 Rating Details
2023-06-27 15:06:28 -0500 Rating Details
2023-06-27 15:02:53 -0500 Rating Details
2023-06-27 14:18:56 -0500 Rating Details
2023-06-27 14:18:05 -0500 Rating Details
2023-06-27 13:52:38 -0500 Rating Details
2023-06-27 13:49:32 -0500 Rating Details
2023-06-27 13:39:59 -0500 Rating Details
2023-06-27 13:38:07 -0500 Rating Details
2023-06-27 13:27:29 -0500 Rating Details
2023-06-27 13:20:29 -0500 Rating Details
2023-06-27 13:01:58 -0500 Rating Details
2023-06-27 12:54:36 -0500 Rating Details
2023-06-28 19:02:31 -0500 Rating Details
2023-06-28 17:25:21 -0500 Rating Details
2023-06-28 17:02:39 -0500 Rating Details
2023-06-28 16:55:38 -0500 Rating Details
2023-06-28 10:18:18 -0500 Rating Details
2023-06-28 08:50:06 -0500 Rating Details
2023-06-28 07:42:24 -0500 Rating Details
2023-06-28 06:48:09 -0500 Rating Details
2023-06-28 04:54:42 -0500 Rating Details
2023-06-28 04:52:08 -0500 Rating Details
2023-06-28 03:33:51 -0500 Rating Details
2023-06-28 03:15:54 -0500 Rating Details
2023-06-28 02:24:10 -0500 Rating Details
2023-06-28 02:22:30 -0500 Rating Details
2023-06-28 02:04:05 -0500 Rating Details
2023-06-28 01:56:35 -0500 Rating Details
2023-06-28 01:21:40 -0500 Rating Details
2023-06-27 23:45:42 -0500 Rating Details
2023-06-27 23:37:27 -0500 Rating Details
2023-06-27 23:15:11 -0500 Rating Details
2023-06-27 22:59:58 -0500 Rating Details
2023-06-27 22:45:48 -0500 Rating Details
2023-06-27 21:22:50 -0500 Rating Details
2023-06-27 21:20:32 -0500 Rating Details
2023-06-27 21:00:31 -0500 Rating Details
2023-06-27 20:26:18 -0500 Rating Details
2023-06-27 20:09:38 -0500 Rating Details
2023-06-27 20:03:15 -0500 Rating Details
2023-06-27 19:58:23 -0500 Rating Details
2023-06-27 19:56:37 -0500 Rating Details
2023-06-27 19:39:43 -0500 Rating Details
2023-06-27 19:35:09 -0500 Rating Details
2023-06-27 19:35:06 -0500 Rating Details
2023-06-27 19:32:43 -0500 Rating Details
2023-06-27 19:32:42 -0500 Rating Details
2023-06-29 16:22:05 -0500 Rating Details
2023-06-29 02:39:50 -0500 Rating Details
2023-06-28 20:28:33 -0500 Rating Details
2023-07-24 15:34:49 -0500 Rating Details